Are two doses of misoprostol after mifepristone for early abortion better than one?

被引:20
作者
Coyaji, K.
Krishna, U.
Ambardekar, S.
Bracken, H.
Raote, V.
Mandlekar, A.
Winikoff, B.
机构
[1] Gynuity Hlth Projects, New York, NY 10010 USA
[2] KEM Hosp, Dept Obstet & Gynaecol, Pune, Maharashtra, India
[3] Larsen & Toubro Hlth Ctr, Bombay, Maharashtra, India
关键词
India; medical abortion; mifepristone; misoprostol; EARLY MEDICAL ABORTION; EARLY-PREGNANCY TERMINATION; RANDOMIZED-TRIAL; VAGINAL MISOPROSTOL; UNITED-STATES; EFFICACY; ACCEPTABILITY; WOMEN; GESTATION; REGIMENS;
D O I
10.1111/j.1471-0528.2006.01208.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective The objective of this study was to determine if a repeat dose of misoprostol following mifepristone or a single dose of misoprostol increases the efficacy of medical termination of pregnancy. Design Randomised, placebo controlled trial. Setting K.E.M. Hospital, Pune, India, and the Health Centre, Larsen and Toubro Limited, Mumbai, India. Sample A total of 300 women seeking an abortion with amenorrhoea of 8 weeks or less. Methods Women were randomised to receive one or two doses of 400 microgram oral misoprostol at the clinic 48 hours after administration of 200 mg mifepristone. Main outcome measure Complete abortion without surgical intervention. Results The repeat administration of misoprostol 400 microgram improved the complete abortion rate from 86 to 92% and significantly reduced the rate of continuing pregnancy from 7 to 1%. Almost all the women who were administered the additional dose of misoprostol were either very satisfied (58%) or satisfied (37%) with the method. Conclusion While an additional oral dose of 400 microgram misoprostol did not significantly increase the rate of complete abortion without surgical intervention, the additional dose did significantly reduce the rate of continuing pregnancies without compromising the acceptability and ease of use of the method.
引用
收藏
页码:271 / 278
页数:8
相关论文
共 21 条
[11]   EARLY TERMINATION OF PREGNANCY WITH MIFEPRISTONE (RU-486) AND THE ORALLY ACTIVE PROSTAGLANDIN MISOPROSTOL [J].
PEYRON, R ;
AUBENY, E ;
TARGOSZ, V ;
SILVESTRE, L ;
RENAULT, M ;
ELKIK, F ;
LECLERC, P ;
ULMANN, A ;
BAULIEU, EE .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (21) :1509-1513
[12]   Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion [J].
Schaff, EA ;
Fielding, SL ;
Westhoff, C .
CONTRACEPTION, 2001, 64 (02) :81-85
[13]   Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy [J].
Schaff, EA ;
Fielding, SL ;
Westhoff, C .
CONTRACEPTION, 2002, 66 (04) :247-250
[14]   Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion - A randomized trial [J].
Schaff, EA ;
Fielding, SL ;
Westhoff, C ;
Ellertson, C ;
Eisinger, SH ;
Stadalius, LS ;
Fuller, L .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (15) :1948-1953
[15]   A pilot study of mifepristone and misoprostol administered at the same time for abortion in women with gestation from 50 to 63 days [J].
Schreiber, CA ;
Creinin, MD ;
Harwood, B ;
Murthy, AS .
CONTRACEPTION, 2005, 71 (06) :447-450
[16]   Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial [J].
Shannon, C. ;
Wiebe, E. ;
Jacot, F. ;
Guilbert, E. ;
Dunn, S. ;
Sheldon, W. R. ;
Winikoff, B. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2006, 113 (06) :621-628
[17]   Early pregnancy termination with mifepristone and misoprostol in the United States [J].
Spitz, IM ;
Bardin, CW ;
Benton, L ;
Robbins, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (18) :1241-1247
[18]  
VANLOOK PFA, 1993, BRIT MED J, V307, P532
[19]   WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: Efficacy [J].
von Hertzen, H ;
Honkanen, H ;
Piaggio, G ;
Bartfai, G ;
Erdenetungalag, R ;
Gemzell-Danielsson, K ;
Gopalan, S ;
Horga, M ;
Jerve, F ;
Mittal, S ;
Ngoc, NTN ;
Peregoudov, A ;
Prasad, RNV ;
Pretnar-Darovec, A ;
Shah, RS ;
Song, S ;
Tang, OS ;
Wu, SC .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2003, 110 (09) :808-818
[20]   Acceptability and feasibility of early pregnancy termination by mifepristone-misoprostol - Results of a large multicenter trial in the United States [J].
Winikoff, B ;
Ellertson, C ;
Elul, B ;
Sivin, I .
ARCHIVES OF FAMILY MEDICINE, 1998, 7 (04) :360-366